This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2023-2024.
Company Filing History:
Years Active: 2023-2024
Title: Yasuaki Anami: Innovator in Antibody Drug Conjugates
Introduction
Yasuaki Anami is a notable inventor based in Houston, Texas. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of antibody drug conjugates. With a total of 2 patents, Anami's work is paving the way for advancements in targeted therapies.
Latest Patents
Anami's latest patents focus on linkers for antibody drug conjugates. In one aspect, the present disclosure provides compounds of specific formulas, wherein the variables are defined within the documentation. Additionally, the patents outline methods for preparing these compounds and detail the composition of antibody drug conjugates that incorporate them. The innovations also include pharmaceutical compositions and methods of use for the disclosed compounds and antibody drug conjugates.
Career Highlights
Yasuaki Anami is affiliated with The University of Texas System, where he continues to engage in groundbreaking research. His work is instrumental in enhancing the efficacy of cancer treatments through innovative drug delivery systems.
Collaborations
Anami collaborates with esteemed colleagues such as Kyoji Tsuchikama and Zhiqiang An. Their combined expertise contributes to the advancement of research in the field of antibody drug conjugates.
Conclusion
Yasuaki Anami's contributions to the field of pharmaceutical sciences through his patents on antibody drug conjugates highlight his role as an innovator. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in targeted therapies.